Skip to main content

Table 1 Comparison demographics and risk behavior at baseline. Reported by individuals with a single HIV test during the study period versus those with repeated HIV tests (those with two or more tests, and the subpopulation with five or more tests)

From: Repeat HIV-testing is associated with an increase in behavioral risk among men who have sex with men: a cohort study

Risk factor/risk behavior (within 12 months prior to test) and demographics

Single testers a

Repeat testers (2 or more tests) a

P value b

Repeat tester (5 or more tests) a

P value b

N

5402

3202

 

814

 

Number of male partners (median, IQR)

5 (3–10)

6 (3–12)

<0.001

6 (4–14)

<0.001

10 or more male partners

1624/5397 (30.1 %)

1120/3197 (35.0 %)

<0.001

319 (39.2 %)

<0.001

Intercourse with females also

594/5389 (11.0 %)

277/3192 (8.7 %)

<0.001

64/813 (7.9 %)

0.007

CIAI with male

3188/5347 (59.6 %)

1974/3170 (62.3 %)

0.016

491/804 (61.1 %)

n.s.

CRAI

2611/5343 (48.9 %)

1664/3167 (52.5 %)

0.001

434/802 (54.1 %)

0.003

CRAI and 5 or more male partners

1544/5342 (28.9 %)

1102/3165 (34.8 %)

<0.001

306/802 (38.2 %)

<0.001

CRAI and 10 or more male partners

892/5342 (16.7 %)

632/3165 (20.0 %)

<0.001

181/802 (22.6 %)

<0.001

CRAI with HIV positive

214/5097 (4.2 %)

121/2947 (4.1 %)

n.s.

19/725 (2.6 %)

0.043

CRAI with PWID

56/5281 (1.1 %)

29/3129 (0.9 %)

n.s.

4/790 (0.5 %)

n.s.

CRAI with sex worker

21/5147 (0.4 %)

9/3052 (0.3 %)

n.s.

1/764 (0.1 %)

n.s.

Worked as sex worker

84/3799 (2.2 %)

45/2004 (2.3 %)

n.s.

8/424 (1.9 %)

n.s.

Syphilis c

101 (1.9 %)

59 (1.8 %)

n.s.

23 (2.8 %)

n.s.

Gonorrhea c

274 (5.1 %)

193 (6.0 %)

n.s.

47 (5.8 %)

n.s.

Chlamydia c

214 (4.0 %)

129 (4.0 %)

n.s.

48 (5.9 %)

0.01

Any STI c

596 (11.0 %)

402 (12.6 %)

0.033

126 (15.5 %)

<0.001

Methamphetamine, not injected

363 (6.7 %)

189 (5.9 %)

n.s.

44 (5.4 %)

n.s.

Non-injection stimulant drug use (i.e. methamphetamine, cocaine, poppers, GHB, ketamine, XTC)

1316 (24.4 %)

765 (23.9 %)

n.s.

176 (21.6 %)

n.s.

IDU

77 (1.4 %)

37 (1.2 %)

n.s.

5 (0.6 %)

n.s.

IDU with shared needles

35/5378 (0.7 %)

7/3180 (0.2 %)

0.006

0

0.021

Demographic data

 Age (years; median, IQR)

33 (26–43)

32 (26–42)

0.011

32 (26–41)

n.s.

 Male

5402 (100 %)

3202 (100 %)

n.s.

814 (100 %)

 

 Hispanic origin

1434/5249 (27.3 %)

850/3105 (27.4 %)

n.s.

203/785 (25.9 %)

n.s.

 Race

<0.001

<0.001

  Caucasian

3513/5066 (69.3 %)

2112/3021 (69.9 %)

n.s.

547/783 (69.9 %)

n.s.

  African-American

317/5066 (6.3 %)

143/3021 (4.7 %)

0.005

39/783 (5.0 %)

n.s.

  Asian

398/5066 (7.9 %)

195/3021 (6.5 %)

0.022

52/783 (6.6 %)

n.s.

  Pacific Islander

142/5066 (2.8 %)

53/3021 (1.8 %)

0.004

11/783 (1.4 %)

0.030

  Native American

37/5066 (0.7 %)

15/3021 (0.5 %)

n.s.

1/783 (0.1 %)

n.s.

  Other

659/5066 (13.0 %)

503/3021 (16.7 %)

<0.001

133/783 (17.0 %)

0.002

  1. CIAI, Condomless insertive anal intercourse; CRAI, Condomless receptive anal intercourse; GHB, Gamma hydroxybutyrate; IDU, Injection drug use; IQR, Inter-quartile range; MSM, Men who have sex with men; n.s., Not significant; PWID, Person who injects drugs; STI, Sexually transmitted infection; XTC, Ecstasy
  2. a Data available from all individuals if denominator not depicted
  3. b Calculated using χ2 or Mann–Whitney U-test
  4. c All self-reported diagnosis within the last 12 months